Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael W Lutz

Showing results (1-10 of 114) with videos related to

Pageof 12
Sort By:
Alzheimer'S & Dementia (New York, N. Y.)|March 1, 2022
Bioinformatics pipeline to guide late-onset Alzheimer's disease (LOAD) post-GWAS studies: Prioritizing transcription regulatory variants within LOAD-associated regionsMichael W Lutz, Ornit Chiba-Falek
Expert Review of Precision Medicine and Drug Development|September 26, 2017
Towards precision medicine in Alzheimer's disease: deciphering genetic data to establish informative biomarkersOrnit Chiba-Falek, Michael W Lutz
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|May 30, 2023
Bioinformatics pipeline to guide post-GWAS studies in Alzheimer's: A new catalogue of disease candidate short structural variantsMichael W Lutz, Ornit Chiba-Falek
Journal of Alzheimer'S Disease : JAD|December 31, 2023
A Continuous Extension of Gene Set Enrichment Analysis Using the Likelihood Ratio Test Statistics Identifies Vascular Endothelial Growth Factor as a Candidate Pathway for Alzheimer's Disease via ITGA5Ali Mahzarnia, Michael W Lutz, Alexandra Badea
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|August 14, 2018
A systems-based model of Alzheimer's diseaseYi Tang, Michael W Lutz, Yi Xing
Biorxiv : the Preprint Server for Biology|September 4, 2023
A Continuous Extension of Gene Set Enrichment Analysis using the Likelihood Ratio Test Statistics Identifies VEGF as a Candidate Pathway for Alzheimer's diseaseAli Mahzarnia, Michael W Lutz, Alexandra Badea
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 3, 2019
Bioinformatics strategy to advance the interpretation of Alzheimer's disease GWAS discoveries: The roads from association to causationMichael W Lutz, Daniel Sprague, Ornit Chiba-Falek
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 23, 2025
Basic Science and PathogenesisMichael W Lutz, Zhaohui Man, Ornit Chiba-Falek
Journal of Alzheimer'S Disease : JAD|December 19, 2022
Novel Genetic Variants in TP37, PIK3R1, CALM1, and PLCG2 of the Neurotrophin Signaling Pathway Are Associated with the Progression from Mild Cognitive Impairment to Alzheimer's DiseaseHuiyue Li, Hongliang Liu, Michael W Lutz, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|March 11, 2018
The effects of the TOMM40 poly-T alleles on Alzheimer's disease phenotypesOrnit Chiba-Falek, William K Gottschalk, Michael W Lutz
Pageof 12

Showing results (1-10 of 114) with videos related to

Sort By:
Pageof 12
Alzheimer'S & Dementia (New York, N. Y.)|March 1, 2022
Bioinformatics pipeline to guide late-onset Alzheimer's disease (LOAD) post-GWAS studies: Prioritizing transcription regulatory variants within LOAD-associated regionsMichael W Lutz, Ornit Chiba-Falek
Expert Review of Precision Medicine and Drug Development|September 26, 2017
Towards precision medicine in Alzheimer's disease: deciphering genetic data to establish informative biomarkersOrnit Chiba-Falek, Michael W Lutz
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|May 30, 2023
Bioinformatics pipeline to guide post-GWAS studies in Alzheimer's: A new catalogue of disease candidate short structural variantsMichael W Lutz, Ornit Chiba-Falek
Journal of Alzheimer'S Disease : JAD|December 31, 2023
A Continuous Extension of Gene Set Enrichment Analysis Using the Likelihood Ratio Test Statistics Identifies Vascular Endothelial Growth Factor as a Candidate Pathway for Alzheimer's Disease via ITGA5Ali Mahzarnia, Michael W Lutz, Alexandra Badea
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|August 14, 2018
A systems-based model of Alzheimer's diseaseYi Tang, Michael W Lutz, Yi Xing
Biorxiv : the Preprint Server for Biology|September 4, 2023
A Continuous Extension of Gene Set Enrichment Analysis using the Likelihood Ratio Test Statistics Identifies VEGF as a Candidate Pathway for Alzheimer's diseaseAli Mahzarnia, Michael W Lutz, Alexandra Badea
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 3, 2019
Bioinformatics strategy to advance the interpretation of Alzheimer's disease GWAS discoveries: The roads from association to causationMichael W Lutz, Daniel Sprague, Ornit Chiba-Falek
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 23, 2025
Basic Science and PathogenesisMichael W Lutz, Zhaohui Man, Ornit Chiba-Falek
Journal of Alzheimer'S Disease : JAD|December 19, 2022
Novel Genetic Variants in TP37, PIK3R1, CALM1, and PLCG2 of the Neurotrophin Signaling Pathway Are Associated with the Progression from Mild Cognitive Impairment to Alzheimer's DiseaseHuiyue Li, Hongliang Liu, Michael W Lutz, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|March 11, 2018
The effects of the TOMM40 poly-T alleles on Alzheimer's disease phenotypesOrnit Chiba-Falek, William K Gottschalk, Michael W Lutz
Pageof 12